|
The following stocks are the leading risers and fallers on AIM on Thursday. ---------- AIM - WINNERS ---------- Poolbeg Pharma PLC, up 13% at 4.18 pence, 12-month range 2.25p-8.50p. The clinical stage biopharmaceutical firm, focused on cancer immunotherapy, reports that the European Patent Office has granted a patent application covering the POLB 001 treatment for severe flu. ---------- Solid State PLC, up 4.7% at 143.90 pence, 12-month range 110.00p-210.00p. The electronics firm, which supplies components to customers in commercial, industrial and defence markets, says its Custom Power has won deals totalling $7.4 million since the end of its half year on September 30. ‘These orders demonstrate the continued progress and benefits of the focused strategy to deliver high-value, high-quality engineered solutions. This approach is strengthening Custom Power’s reputation as the go-to provider of advanced battery technology solutions for customers with demanding and mission-critical applications,’ Solid State says. ---------- AIM - LOSERS ---------- Artisanal Spirits Co PLC, down 20% at 32.45p, 12-month range 31.00p-57.00p. The Scotch Malt Whisky Society owner says it will book one-off non-cash hits this year. ‘The recent government shutdown in the US has created a substantial backlog in the regulatory approval of new product labels,’ it explains. The duration for approval that it has been quoted is over six weeks, ‘versus the normal 72 hour process’ which the Alcohol & Tobacco Tax & Trade Bureau usually operates with. ‘This directly impacts SMWS due to the unique model of the society’s limited-edition whiskies whereby each new bottle sold in the US requires a certificate of label approval,’ Artisanal says. The firm says $3.2 million of shipments due for November will not be able to clear US customs before the end of the year. ‘These circumstances are entirely outside of the company’s control,’ it says. As a result, it expects a non-cash impact on 2025 results to the tune of a £2 million hit to earnings before interest, tax, depreciation and amortisation and £2.5 million to revenue. In addition, it expects a separate hit of £1 million to £1.5 million to its Ebitda this year stemming from a planned change in its route to market. It looks to have ‘direct relationships’ with partners, which it says will offer ‘substantial recurring cost and efficiency benefits’. ‘We have decided to accelerate this move, as the [Alcohol & Tobacco Tax & Trade Bureau] impact means that the stocks held by our existing partner will be significantly reduced, making a transition to this new route-to-market at the end of March 2026 (when the current contract expires) simpler and more efficient to execute,’ it adds. This Ebitda hit reflects ‘stock that is currently in market and is expected to still be held by our existing importer’. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
